Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06558981
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-26
Brief Title:
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Role of Adjuvant Radiotherapy in High Risk Locally Advanced Differentiated Thyroid Cancera 11 Randomized Phase III Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a phase III randomized controlled clinical trial on the role of adjuvant radiotherapy in high-risk locally advanced differentiated thyroid cancer Patients who meet the inclusion criteria were randomly assigned 11 to either the experimental group adjuvant radiotherapyRAI or the control group RAI with LRFS as the primary endpoint of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None